Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies.

Sascha Louise HeckertJohanna M MaassenIsabell NevinsPaul BaudoinGerda M Steup-BeekmanTom W J HuizingaSytske Anne BergstraCornelia F Allaart

Published in: Rheumatology (Oxford, England) (2024)

At 12/20 years after treatment start, the majority of RA and UA patients who had been treated to target low DAS or DAS remission were in DAS remission and had limited functional disability. Radiographic damage progression was mild although not completely suppressed.

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
ankylosing spondylitis
interstitial lung disease
oxidative stress
newly diagnosed
systemic sclerosis
replacement therapy